x

Global Transforming Growth Factor Beta 1 Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Published Date: 2021-02-25   |   Pages: 111   |   Tables: 143   | Report Id: 2792151   | Hits: 35 |   Pharma & Healthcare

category cover


Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

North America is the largest consumption place, with a consumption market share nearly 61.5% In 2018. Following North America, Asia-Pacific and Europe is the second two largest consumption places with the consumption market share of 18% and 17%, respectively.


In 2020, the global Transforming Growth Factor Beta 1 market size was US$ 1628.4 million and is forecast to 3062.2 million US in 2027, growing at a CAGR of 11.1% during the 2021-2027. In this study, 2020 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Transforming Growth Factor Beta 1.

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Transforming Growth Factor Beta 1 market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Transforming Growth Factor Beta 1 market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Transforming Growth Factor Beta 1 market. Readers of the report can become informed about current and future trends of the global Transforming Growth Factor Beta 1 market and how they will impact market growth during the forecast period.


By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E


Segment by Type

Pirfenidone

Galunisertib

Others


Segment by Application

IPF

Cancer

Others


By Company

Roche

Shionogi Ltd

Acceleron Pharma Inc

Genzyme Corp

Isarna Therapeutics GmbH

Scholar Rock

Sirnaomics Inc

Eli Lilly and Co

Formation Biologics Inc

Novartis AG

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

Global Transforming Growth Factor Beta 1 Industry

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
More Clients...